Steatotic Liver Disease

Slide 1 · Steatotic Liver Disease

An integrated pathologic framework for alcohol- and metabolism-associated injury

Alcohol-associated injury

Metabolic dysfunction

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Distinguish hepatic steatosis, steatohepatitis and progressive fibrosis.

Explain why alcohol exposure and insulin resistance produce overlapping injury patterns.

Recognize the key morphologic features and their clinicopathologic significance.

Explain why etiologic classification requires clinical information in addition to histology.

Slide 3 · Steatotic liver disease: An umbrella concept

The Robbins section groups alcohol-associated liver disease and MASLD because their morphologic patterns overlap.

The same biopsy patterns can result from different or coexisting etiologic drivers.

The initiating exposure, systemic context and disease stage are therefore essential for interpretation.

Alcohol-associated liver disease

Shared hepatic lesions

Metabolic dysfunction–associated SLD

Schematic conceptual relationship

Slide 4 · Common morphologic spectrum

Simple steatosis

Steatohepatitic injury

Progressive fibrosis

Cirrhosis

These categories overlap: Fibrosis may coexist with ongoing hepatocellular injury.

This is a teaching continuum—not a claim that every patient passes through all stages.

Slide 5 · Two major etiologic contexts

Alcohol-associated disease

Ethanol metabolism changes hepatocyte redox balance.

Acetaldehyde, CYP2E1 induction and gut-derived inflammatory signaling add injury.

Exposure and host susceptibility influence disease severity.

Metabolic dysfunction–associated disease

Insulin resistance and dysfunctional adipose tissue increase hepatic lipid burden.

Oxidative stress and cytokine signaling promote injury and scarring.

Cardiometabolic comorbidity is central to classification.

Slide 6 · Shared injury versus differing initiating factors

Shared microscopic lesions

Steatosis and ballooned hepatocytes.

Lobular inflammatory infiltrates and cell death.

Pericellular/perisinusoidal fibrosis progressing to cirrhosis.

Different clinical evidence

Pattern and quantity of alcohol consumption.

Obesity, insulin resistance, diabetes or dyslipidemia.

Other potential chronic liver diseases and exposures.

Histology describes the injury; History and evaluation identify the likely cause.

Slide 7 · Overlap includes combined alcohol and metabolic risk

Alcohol-related injury and MASLD may coexist rather than being mutually exclusive.

Robbins recognizes an overlap category termed MetALD for MASLD with increased alcohol intake.

Concomitant viral infection, iron overload or other liver injury can amplify fibrosis risk.

Metabolic risk

Alcohol exposure

Combined hepatic risk

Schematic conceptual overlap

Slide 8 · Why a histologic diagnosis is not enough

Steatohepatitis is a pattern of hepatocellular injury, not a unique etiologic signature.

Neutrophils and Mallory hyaline may favor alcohol-associated injury, but are not exclusive.

An integrated diagnosis combines biopsy findings with alcohol, metabolic and other clinical information.

Do not diagnose alcohol causation solely from a characteristic-looking biopsy.

Slide 9 · Acinar zonation helps localize injury

Zone 3 is the centrilobular/perivenular region of the hepatic acinus.

Alcohol-associated changes characteristically begin in zone 3 and extend outward.

Early perisinusoidal fibrosis in steatohepatitis is often centered in this region.

CV

Zone 3

Zone 2

Zone 1

Portal

CV = central vein; Alcohol-associated injury begins near zone 3

Simplified acinar axis (not a scaled anatomical diagram)

Slide 10 · Gross appearance of fatty liver

With substantial fat accumulation, the liver may be enlarged, soft, yellow and greasy.

The source describes severe hepatomegaly in long-standing alcohol-associated steatosis.

Gross appearance indicates steatosis but does not independently identify its cause.

Slide 11 · Macrovesicular steatosis: Nuclear displacement

Large lipid vacuoles expand the cytoplasm and displace the nucleus peripherally.

Small droplets may merge into one dominant vacuole within a hepatocyte.

Macrovesicular change predominates in alcohol-associated liver disease.

Schematic — not a histologic specimen

Slide 12 · Macrovesicular and microvesicular patterns

Macrovesicular steatosis

Large optically empty vacuole; Eccentric, compressed nucleus.

Common pattern in alcohol-related disease and MASLD.

Often prominent within a centrilobular distribution.

Small-droplet / microvesicular change

Many smaller fat droplets may occupy the cytoplasm.

Alcohol-associated foamy degeneration is a rare exception to the usual macrovesicular pattern.

Patterns require careful morphologic description.

Slide 13 · Lipid accumulation can precede cell injury

Increased lipid delivery or synthesis

Hepatocyte triglyceride storage

Steatosis

Additional stress → injury

Steatosis alone is not synonymous with steatohepatitis.

In alcohol-associated disease, early fatty change can regress with abstinence.

Slide 14 · Ballooning signifies hepatocellular injury

Ballooned hepatocytes are enlarged, with rarefied or cleared cytoplasm.

The appearance is associated with cytoskeletal disruption and cell injury.

Ballooning is central to recognizing steatohepatitic injury in both etiologic settings.

Schematic — not a histologic specimen

Slide 15 · Mallory hyaline reflects cytoskeletal injury

Mallory hyaline consists of aggregated, partially degraded and ubiquitinated cytokeratins.

Keratins 8 and 18 in these inclusions.

These inclusions can accompany ballooned hepatocytes but are not specific for alcohol-associated disease.

Cytoskeletal stress

Keratins 8/18 aggregate

Mallory hyaline

Schematic; Not a microscopic depiction

Slide 16 · Inflammation in steatohepatitis

Lobular injury

Lobular inflammatory foci accompany steatosis and ballooning.

Macrophages and lymphocytes participate in the injury pattern.

Spotty apoptosis or necrosis may be present.

Alcohol-associated tendency

Neutrophils are often more conspicuous than in MASH.

Neutrophils may cluster near ballooned cells with Mallory hyaline.

The degree of inflammation alone is not a definitive etiologic test.

Slide 17 · Cell death extends beyond fat storage

Metabolic and oxidative stresses can damage hepatocyte plasma and mitochondrial membranes.

Steatohepatitis may show spotty hepatocyte necrosis or apoptosis.

Progressive injury activates inflammatory and wound-healing responses.

Oxidative / cellular stress

Cell injury and death

Inflammatory response

Schematic sequence

Slide 18 · Pericellular fibrosis: “chicken wire” pattern

Fine perisinusoidal collagen surrounds individual or clustered hepatocytes.

Early fibrosis is frequently concentrated around zone 3 and central venules.

A connective-tissue stain such as Masson trichrome can help demonstrate delicate fibrosis.

Zone 3 pericellular

Portal / periportal

Bridging → cirrhosis

Schematic fibrosis sequence

Slide 19 · Fibrosis changes the architecture of the liver

Pericellular / perivenular fibrosis

Portal or periportal fibrosis

Bridging septa

Cirrhosis

The sequence summarizes typical progression described for steatohepatitis.

Established cirrhosis includes nodularity and deranged vascular perfusion.

Slide 20 · Burned-out disease may lose its fat

In advanced cirrhosis, visible steatosis and ballooning may be diminished or absent.

Historical metabolic or alcohol-associated exposure may remain crucial to etiologic attribution.

Absence of current steatosis does not exclude steatotic disease as the initiating process.

Zone 3 pericellular

Portal / periportal

Bridging → cirrhosis

Schematic fibrosis sequence

Slide 21 · Morphologic findings: What each establishes

Finding

Morphologic significance

Limitation

Steatosis

Hepatic fat storage

Not etiologically specific

Ballooning

Hepatocellular damage

Not exclusive to alcohol or MASH

Lobular inflammation

Active inflammatory injury

Inflammatory intensity overlaps

Pericellular fibrosis

Chronic wound-healing response

Stage, not a unique cause

Slide 22 · Interpretation pitfall: Pattern versus diagnosis

An observed histologic lesion is not equivalent to a complete clinical disease classification.

Steatohepatitis can coexist with viral, toxic or inherited liver disease.

Morphology, exposure history, metabolic profile and exclusion of alternative causes must be integrated.

Slide 23 · Alcohol-associated disease comprises overlapping forms

Alcohol-associated steatosis

Alcohol-associated hepatitis

Fibrosis / cirrhosis

These lesions can coexist in the same liver.

Some patients present with cirrhosis without earlier stages being clinically recognized.

Slide 24 · Ethanol metabolism shifts hepatic redox balance

Ethanol oxidation

Generation of excess NADH

Altered hepatocyte redox state

Triglyceride accumulation

Ethanol metabolism by alcohol and aldehyde dehydrogenases increases NADH production.

The resulting metabolic imbalance favors lipid retention.

Slide 25 · How altered redox balance promotes steatosis

Less lipid disposal

Raised NADH suppresses fatty acid oxidation.

Reduced oxidative disposal leaves more substrate for storage.

Triglycerides accumulate in hepatocyte vacuoles.

More hepatic lipogenesis

Alcohol increases expression of lipogenic enzymes.

Peripheral lipid mobilization can increase hepatic lipid supply.

Impaired lipoprotein secretion may amplify retention.

Slide 26 · Lipoprotein export is another point of failure

The amount of hepatic lipid depends on input, synthesis, oxidation and export.

Alcohol may impair assembly and secretion of lipoproteins.

This effect can act together with increased synthesis and reduced oxidation to cause steatosis.

More input / synthesis

Less oxidation / export

Net lipid storage

Simplified lipid balance

Slide 27 · Acetaldehyde causes more than metabolic change

Acetaldehyde is a reactive product of ethanol metabolism.

It promotes lipid peroxidation and acetaldehyde–protein adduct formation.

Cytoskeletal, membrane and potentially immune-mediated effects add to hepatocellular injury.

Ethanol → acetaldehyde

Protein adducts / lipid injury

Membrane + cytoskeletal dysfunction

Source-based mechanistic summary

Slide 28 · CYP2E1 links ethanol exposure to oxidative stress

High alcohol exposure

Hepatic CYP2E1 induction

Reactive oxygen species

Protein / membrane / mitochondrial injury

CYP2E1 is a microsomal cytochrome P450 enzyme.

Oxidative injury can promote hepatocyte apoptosis.

Slide 29 · Reduced antioxidant defense worsens injury

Alcohol disrupts hepatic methionine metabolism.

Lower glutathione availability sensitizes the liver to oxidative damage.

Altered homocysteine metabolism may contribute to endoplasmic reticulum stress.

Methionine disruption

Reduced glutathione

Higher oxidative vulnerability

Mechanistic schematic

Slide 30 · Alcohol-associated disease engages the gut–liver axis

Alcohol-associated gut barrier effects

Increased portal endotoxin exposure

Kupffer-cell inflammatory signaling

Hepatic cytokines and injury

Gut-derived lipopolysaccharide and innate immune activation.

The contribution is biologically plausible but individual causal pathways remain complex.

Slide 31 · CD14–TLR4 signaling contributes to inflammation

Gut-derived LPS can interact with CD14 on hepatic Kupffer cells.

TLR4 activation drives inflammatory cytokine and chemokine release.

DAMPs from dying hepatocytes can further activate innate immune pathways.

LPS / CD14

TLR4 signaling

Cytokines + chemokines

Inflammatory injury

Simplified innate immune pathway

Slide 32 · Alcohol injury varies among exposed individuals

Host susceptibility

Risk is not determined by alcohol dose alone.

Sex-related sensitivity is described.

Genetic variants in alcohol metabolism and immune responses may modify injury.

Concurrent hepatic insults

Chronic viral hepatitis or iron overload can amplify damage.

Metabolic steatohepatitis can overlap with alcohol injury.

A multifactorial evaluation is needed for mixed exposures.

Slide 33 · Genetic variation may influence alcohol responses

Twin data support a genetic contribution to alcohol-associated disease susceptibility.

Alcohol-metabolizing enzymes differ in activity among individuals.

Reduced aldehyde dehydrogenase activity in an ALDH2 variant associated with alcohol intolerance.

Slide 34 · Alcohol-associated morphology often begins in zone 3

Early lipid deposition and subsequent fibrosis tend to be prominent in centrilobular regions.

More severe disease can extend outward toward portal tracts.

Pattern is suggestive but is not a standalone etiologic diagnostic test.

CV

Zone 3

Zone 2

Zone 1

Portal

CV = central vein; Alcohol-associated injury begins near zone 3

Simplified acinar axis (not a scaled anatomical diagram)

Slide 35 · Alcohol-associated hepatitis: Histologic pattern

Hepatocellular injury

Ballooned hepatocytes, sometimes with Mallory hyaline.

Spotty necrosis/apoptosis; More extensive injury in severe cases.

Mixed steatosis may persist.

Associated response

Neutrophilic lobular infiltration is often conspicuous.

Lobular macrophages and lymphocytes contribute.

Zone 3 pericellular or perivenular fibrosis may accompany injury.

Slide 36 · Fibrosis also distorts hepatic microcirculation

Chronic alcohol-associated damage produces pericellular and perivenular scarring.

Progressive fibrosis may bridge vascular compartments and form nodules.

Fibrous obliteration of venous structures contributes to abnormal perfusion in established cirrhosis.

Zone 3 pericellular

Portal / periportal

Bridging → cirrhosis

Schematic fibrosis sequence

Slide 37 · Clinical presentation: Alcohol-associated steatosis

Patients may have hepatomegaly with only mild biochemical abnormalities.

Severe hepatic dysfunction is unusual when isolated steatosis is present.

Alcohol cessation and adequate nutrition can reverse early fatty change.

Slide 38 · Clinical presentation: Alcohol-associated hepatitis

An episode may follow heavy drinking and appear as acute systemic illness.

Symptoms can include malaise, anorexia, weight loss and upper abdominal discomfort.

Tender hepatomegaly, jaundice and inflammatory blood-test changes may be observed.

Severe presentations may resemble acute liver failure or cholestatic disease.

Slide 39 · Biochemistry can support—but not prove—etiology

Alcohol-associated pattern

AST is often higher than ALT.

A ratio around 2:1 or greater may support suspicion when the history is uncertain.

Hyperbilirubinemia and alkaline phosphatase elevation can accompany active hepatitis.

Important interpretive limits

AST:ALT ratio alone is neither a definitive test nor a histologic classification.

Severity and clinical context govern interpretation.

Coexisting liver conditions must remain in the differential.

Slide 40 · Cirrhosis is the major advanced consequence

Regenerative nodules and fibrous septa remodel the liver architecture.

Portal hypertension and impaired synthetic capacity underlie many complications.

Liver failure, hemorrhage, infection and hepatocellular carcinoma are recognized late risks.

Slide 41 · Withdrawal can change the path of alcohol injury

Alcohol cessation

Reduction of continuing injury

Steatosis / early scar may regress

Established cirrhosis often persists

The reversibility of histologic change depends on stage.

Complete reversal of alcohol-associated cirrhosis is uncommon in the source text.

Slide 42 · MASLD and MASH: Definitions in the source

MASLD denotes hepatic steatosis associated with cardiometabolic risk, in the absence of another sufficient explanation.

MASH describes MASLD with steatohepatitic hepatocellular injury.

The textbook contrasts the newer names with NAFLD and NASH terminology.

Metabolic risk + steatosis

MASLD

Steatohepatitic histology

MASH

Classification concept; Full diagnostic assessment is required

Slide 43 · Cardiometabolic context is foundational

Commonly associated conditions

Obesity, particularly increased visceral adipose mass.

Type 2 diabetes mellitus and insulin resistance.

Dyslipidemia and metabolic syndrome.

Why context matters

Metabolic comorbidity raises pretest suspicion.

It also predicts associated extrahepatic risk.

The presence of metabolic risk does not automatically exclude an additional hepatic cause.

Slide 44 · MASLD requires evaluation beyond steatosis

The textbook framework includes steatosis and cardiometabolic risk factors.

History must address alcohol exposure, medications and secondary causes of liver injury.

Hepatitis C, Wilson disease and other potential etiologies must be considered where relevant.

Do not substitute a fatty liver imaging result for a complete etiologic evaluation.

Slide 45 · Insulin-resistant adipose tissue increases lipid flux

Insulin resistance

Dysfunctional visceral adipocytes

Greater free fatty acid release

Hepatic triglyceride storage

The source emphasizes excess free fatty acid delivery to hepatocytes.

Visceral adipose tissue also produces inflammatory mediators.

Slide 46 · Adipose inflammation contributes to MASH biology

Dysfunctional adipose tissue releases inflammatory signals, including TNF-α.

This proinflammatory environment can aggravate hepatocyte stress.

The degree of steatohepatitis varies despite similar levels of insulin resistance.

Adipose dysfunction

TNF-α + increased fatty acids

Hepatocyte stress and injury

Schematic; Multifactorial relationship

Slide 47 · Lower adiponectin reduces lipid disposal

Insulin-resistant adipose tissue may release less adiponectin.

This reduces fatty acid oxidation in skeletal muscle and increases the substrate available to the liver.

The combined effects favor hepatocellular triglyceride accumulation.

Reduced adiponectin

Reduced peripheral fatty acid oxidation

More hepatic lipid uptake

Based on source pathogenesis discussion

Slide 48 · Lipophagy is a second lipid-clearance mechanism

Lipophagy is selective autophagic turnover of intracellular lipid stores.

Reduced hepatocyte lipolysis through altered lipophagy in MASLD.

Decreased lipid clearance can reinforce greater fatty acid delivery and storage.

Reduced lipophagy

Persistent intracellular lipid

Hepatocellular steatosis

Mechanism summarized from textbook

Slide 49 · Oxidative stress links steatosis to injury

Hepatocyte lipid accumulation

Lipid peroxidation under oxidative stress

Membrane / mitochondrial damage

Apoptosis, necrosis and inflammation

The pathogenesis is multifactorial; Fat accumulation alone does not predict all outcomes.

Inflammatory responses may amplify damage after the initial insult.

Slide 50 · Additional factors linked to MASLD progression

Diet and microbiome

High-fructose diets are associated with more fibrosis in the source discussion.

Trans-fat intake may contribute to liver injury.

Gut-derived endotoxin is associated with inflammatory activation.

Hypoxia and additional liver injury

Obstructive sleep apnea may contribute via intermittent hypoxia.

Concurrent hemochromatosis or other chronic injury can accelerate fibrosis.

These associations do not establish a single causal pathway for every patient.

Slide 51 · Cytokines connect hepatocyte injury to fibrosis

Hepatocyte damage

Kupffer-cell signaling: TNF-α / TGF-β

Stellate-cell activation

Collagen deposition

Persistent wound-healing activity produces pericellular scarring.

With progression, bridging fibrosis and cirrhosis develop.

Slide 52 · Histologic triad of MASH

Component

What the pathologist looks for

Interpretation

Steatosis

Fat in ≥5% of hepatocytes

Establishes hepatic steatosis

Ballooning

Enlarged, injured hepatocytes

Required steatohepatitic injury

Lobular inflammation

Inflammatory foci in the lobule

Required component of pattern

Slide 53 · MASH fibrosis often begins perisinusoidally

Zone 3 pericellular collagen deposition may have a fine chicken-wire pattern.

Trichrome stain can reveal scars that are inconspicuous on routine H&E.

Later disease often shows periportal fibrosis, bridging and cirrhosis.

Zone 3 pericellular

Portal / periportal

Bridging → cirrhosis

Schematic fibrosis sequence

Slide 54 · Steatohepatitis activity and fibrosis are distinct

Inflammatory activity

Steatosis, ballooning and lobular inflammatory injury.

May fluctuate with changing exposures or metabolic control.

Cannot substitute for an assessment of fibrosis.

Fibrosis burden

Represents accumulated extracellular matrix and architecture change.

Advanced fibrosis increases risk of major liver outcomes.

May persist even when steatosis is less apparent.

Slide 55 · Adult and pediatric MASLD differ

Typical adult pattern

Zone 3 pericellular and perisinusoidal fibrosis is emphasized.

Steatosis, lobular inflammation and ballooning are central when MASH develops.

Fibrosis progression may produce bridging septa.

Pediatric pattern

Steatosis is frequently more diffuse.

Portal fibrosis may be more prominent than centrilobular fibrosis.

Ballooning may be absent.

Do not transfer adult histologic expectations uncritically to pediatric liver biopsies.

Slide 56 · MASLD can be clinically silent

Patients with steatosis alone are commonly asymptomatic.

Liver fat may be detected incidentally on abdominal imaging.

Some patients with MASH have fatigue or right upper abdominal discomfort with hepatomegaly.

Biochemical abnormalities may be present despite minimal symptoms.

Slide 57 · Imaging and biopsy answer different questions

Imaging / clinical assessment

Imaging can identify hepatic fat accumulation.

Metabolic comorbidities and laboratory studies frame the likely disease context.

Other causes of injury must be considered.

Liver biopsy

Shows ballooning and lobular inflammation needed for histologic MASH.

Provides direct assessment of fibrosis.

Can assist when multiple etiologies are plausible.

Slide 58 · A structured differential diagnosis avoids attribution error

Obtain alcohol history and relevant medication/exposure history.

Evaluate for viral hepatitis, autoimmune conditions and metabolic or inherited liver disease where indicated.

Look for possible dual etiologies rather than requiring exactly one cause.

Interpret fibrosis and inflammation in the complete clinicopathologic context.

Slide 59 · Important complications extend beyond the liver

Progressive liver disease

Advanced fibrosis and decompensated cirrhosis.

Portal hypertension, hepatic dysfunction and hepatocellular carcinoma.

In advanced stages, the fatty lesion may be less visible.

Systemic consequences

Metabolic syndrome often coexists with cardiovascular disease.

Cardiovascular disease as a frequent cause of death in MASH.

Overall risk is not captured by liver histology alone.

Slide 60 · Alcohol-associated hepatitis versus MASH

Domain

Alcohol-associated pattern

MASH pattern

Driver

Ethanol exposure and susceptibility

Metabolic dysfunction / insulin resistance

Histology

Steatosis, ballooning, inflammation, fibrosis

Same core lesions; overlap substantial

Typical tendency

More neutrophils / Mallory hyaline on average

Often relatively more steatosis

Identification

History and clinicopathologic assessment

Metabolic context and etiologic assessment

Slide 61 · Histologic overlap is a deliberate diagnostic warning

Alcohol-associated steatohepatitis and MASH cannot be reliably distinguished histologically.

Features reported as more common in alcohol-associated hepatitis are probabilistic tendencies.

Etiologic attribution requires a careful account of exposure, metabolic features and concurrent disorders.

No single pathologic feature is an alcohol-specific biomarker.

Slide 62 · Case application: Acute hepatitis after heavy drinking

Clinical vignette

A patient develops jaundice, tender hepatomegaly and elevated aminotransferases after a period of heavy alcohol intake.

Interpretation question

Which elements support alcohol-associated hepatitis, and what remains uncertain?

The exposure and clinical syndrome support alcohol-associated injury. The diagnosis still requires evaluation for other causes; Steatohepatitic biopsy changes would not prove alcohol as the only etiology.

Slide 63 · Case application: Incidental steatosis with diabetes

Clinical vignette

Imaging identifies fatty liver in an asymptomatic patient with type 2 diabetes and increased visceral adiposity.

Interpretation question

Can imaging alone establish MASH or advanced fibrosis?

No. The findings raise suspicion for MASLD, but imaging-detected steatosis does not demonstrate the biopsy-defined inflammatory/ballooning pattern of MASH or provide histologic fibrosis staging.

Slide 64 · Dual risk factors change the interpretation

Consider both etiologic drivers

Relevant alcohol intake and metabolic dysfunction may coexist.

Some patients have viral hepatitis, iron overload or other simultaneous injury.

The pathologist should communicate pattern and stage precisely.

Clarify the diagnostic question

Is steatosis present?

Is there active steatohepatitis?

How much fibrosis is present, and what is the likely clinical cause?

Slide 65 · Integrated high-yield synthesis

Steatotic liver disease spans relatively reversible fat storage to inflammatory injury, fibrosis and cirrhosis.

Alcohol and metabolic dysfunction use different upstream mechanisms but converge on overlapping morphologic lesions.

Ballooning, lobular inflammation and pericellular fibrosis are central histologic concepts.

Etiology is assigned clinically; Severity and prognosis depend strongly on fibrosis and complications.

Slide 66 · Source and interpretation notes

Primary source: Robbins, Cotran & Kumar, Pathologic Basis of Disease, 11th ed. (2026), Chapter 18, “Steatotic Liver Disease,” pp. 766–771.

Comparative content draws from the immediately adjacent “Alcohol-Associated Liver Disease” and “Metabolic Dysfunction–Associated Steatotic Liver Disease” sections.

All diagrams are original, simplified, editable PowerPoint schematics; they do not depict observed specimens or reproduce the textbook’s figures.

Source material was available as extracted Markdown. Original chapter PDF and licensed textbook images were not available for figure-level verification.